Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zander

Showing results (291-300 of 456) with videos related to

Pageof 46
Sort By:
Journal of Hematotherapy & Stem Cell Research|May 22, 2001
Influence of preharvest tumor cell contamination in bone marrow or blood does not predict resultant tumor cell contamination of granulocyte colony-stimulating factor mobilized stem cellsW Krüger, N Kröger, F Tögel, et al.
Transfusion|January 3, 2001
Immunomagnetic tumor cell selection--implications for the detection of disseminated cancer cellsW Krüger, C Datta, A Badbaran, et al.
Journal of Hematotherapy & Stem Cell Research|June 14, 2003
Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantationNatalja Fehse, Boris Fehse, Nicolaus Kröger, et al.
Stem Cells and Development|June 3, 2016
Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted MicePierre Abramowski, Susanne Krasemann, Thomas Ernst, et al.
Bone Marrow Transplantation|February 1, 1990
Double intensification with amsacrine/high dose ara-C and high dose chemotherapy with autologous bone marrow transplantation produces durable remissions in acute myelogenous leukemiaJ A Spinolo, K A Dicke, L J Horwitz, et al.
Medical Oncology (Northwood, London, England)|June 26, 1999
Tumour cell detection in G-CSF mobilised stem cell harvests of patients with breast cancerW Krüger, F Tögel, N Kröger, et al.
Anticancer Research|January 25, 2008
Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantationEray Goekkurt, Jan Stoehlmacher, Christian Stueber, et al.
Cancer Treatment Reports|January 1, 1981
Early pulmonary toxicity after administration of high-dose BCNUJ P Litam, D H Dail, G Spitzer, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1984
Repeated high-dose cyclophosphamide, BCNU and VP-16-213 and autologous bone marrow transplantation in adult acute lymphocytic leukemia in first remissionL Vellekoop, K A Dicke, A R Zander, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantationFrancis Ayuk, Galina Diyachenko, Tatjana Zabelina, et al.
Pageof 46

Showing results (291-300 of 456) with videos related to

Sort By:
Pageof 46
Journal of Hematotherapy & Stem Cell Research|May 22, 2001
Influence of preharvest tumor cell contamination in bone marrow or blood does not predict resultant tumor cell contamination of granulocyte colony-stimulating factor mobilized stem cellsW Krüger, N Kröger, F Tögel, et al.
Transfusion|January 3, 2001
Immunomagnetic tumor cell selection--implications for the detection of disseminated cancer cellsW Krüger, C Datta, A Badbaran, et al.
Journal of Hematotherapy & Stem Cell Research|June 14, 2003
Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantationNatalja Fehse, Boris Fehse, Nicolaus Kröger, et al.
Stem Cells and Development|June 3, 2016
Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted MicePierre Abramowski, Susanne Krasemann, Thomas Ernst, et al.
Bone Marrow Transplantation|February 1, 1990
Double intensification with amsacrine/high dose ara-C and high dose chemotherapy with autologous bone marrow transplantation produces durable remissions in acute myelogenous leukemiaJ A Spinolo, K A Dicke, L J Horwitz, et al.
Medical Oncology (Northwood, London, England)|June 26, 1999
Tumour cell detection in G-CSF mobilised stem cell harvests of patients with breast cancerW Krüger, F Tögel, N Kröger, et al.
Anticancer Research|January 25, 2008
Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantationEray Goekkurt, Jan Stoehlmacher, Christian Stueber, et al.
Cancer Treatment Reports|January 1, 1981
Early pulmonary toxicity after administration of high-dose BCNUJ P Litam, D H Dail, G Spitzer, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1984
Repeated high-dose cyclophosphamide, BCNU and VP-16-213 and autologous bone marrow transplantation in adult acute lymphocytic leukemia in first remissionL Vellekoop, K A Dicke, A R Zander, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantationFrancis Ayuk, Galina Diyachenko, Tatjana Zabelina, et al.
Pageof 46